Form 4: Select Medical Holdings Corp: Insider Transactions Detailed

Robert A. Ortenzio reports significant changes in beneficial ownership of Select Medical Holdings Corp. common stock, primarily related to a merger agreement.

Summary

• Robert A. Ortenzio, Executive Chairman and a 10% owner of Select Medical Holdings Corporation, has filed a Form 4 detailing transactions related to the company's merger.
• The transactions occurred on June 30, 2026, and involve the disposition of common stock.
• These dispositions are in connection with an Agreement and Plan of Merger entered into on March 2, 2026.
• Ortenzio contributed 6,674,010 common shares and 407,778 restricted shares to Parent (Stallion Intermediate Corporation) in exchange for Parent Common Shares, which were then exchanged for interests in Stallion Group Parent, LP.
• The Robert A. Ortenzio Descendants Trust contributed 1,000,000 common shares to Parent, also in exchange for Parent Common Shares and subsequently interests in Stallion Group Parent, LP.
• The Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio, Kevin M. Ortenzio, and Madeline G. Ortenzio each contributed 280,415 common shares to Parent under similar exchange terms.
• A portion of the common stock reported was converted into the right to receive $16.50 per share in cash without interest at the effective time of the merger.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it details significant stock dispositions by a key insider, it is directly tied to a merger agreement, indicating a structured corporate event rather than a distress sale or opportunistic trading.

Positives

• The filing indicates a cash payout of $16.50 per share for certain common stock conversions, providing a clear value realization for those shares.
• The transactions are part of a merger agreement, which can often lead to strategic growth or enhanced shareholder value.

Negatives

• The filing details the disposition of a significant number of shares by a key insider, which could be interpreted negatively if not for the context of a merger.
• The exact total value of the transactions is not explicitly stated, only the per-share cash conversion amount for a portion of the shares.

Risks

• The primary risk is the completion of the merger as outlined in the Agreement and Plan of Merger, as any failure to close could impact the value of the transactions.
• The filing does not detail specific risks associated with the merger itself, but the nature of such transactions inherently carries integration and strategic risks.

Future Outlook

The future outlook is tied to the successful completion of the merger agreement. The filing itself does not provide forward-looking financial guidance for Select Medical Holdings Corporation as an independent entity post-merger.

Management Comments

• The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
• This Form 4 reports securities disposed of under the Agreement and Plan of Merger.

Industry Context

StockSavvy.ai notes that Form 4 filings related to mergers are common and signal significant corporate events. The details provided here are typical for an executive chairman participating in a going-private transaction or acquisition.

Related Party Transactions

• The filing details transactions involving trusts and entities associated with Robert A. Ortenzio, including The Robert A. Ortenzio Descendants Trust and The Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio, Kevin M. Ortenzio, and Madeline G. Ortenzio. These are reported as part of the merger process.

Stakeholder Impact

• Shareholders: Those holding common stock will be directly impacted by the merger, with a portion of their shares being converted to cash at $16.50 per share.
• Management: Robert A. Ortenzio, as Executive Chairman, is a key participant in the merger, with his beneficial ownership changing significantly.
• Creditors: The impact on creditors will depend on the financial structure and terms of the acquiring entity post-merger.

Next Steps

• The primary next step is the completion of the merger transaction as per the Agreement and Plan of Merger.
• Further filings may be required to report changes in beneficial ownership post-merger, depending on the structure of the acquiring entity.

Key Dates

Keywords

Form 4, Insider Trading, Select Medical Holdings Corp, SEM, Merger Agreement, Beneficial Ownership, Robert A. Ortenzio, Stock Disposition, SEC Filing